11.78
price down icon7.90%   -1.01
after-market Dopo l'orario di chiusura: 12.15 0.37 +3.14%
loading

Denali Therapeutics Inc Azioni (DNLI) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
14.54
- 1.267 294.12 35.14
Operating Expenses
0.24%
132.25
132.57 115.06 123.64 155.96
Benefits Costs and Expenses
116.34
- - - -
Costs And Expenses
0.24%
132.25
132.57 115.06 123.64 155.96
Operating Income/Loss
11.21%
-117.72
-132.57 -113.80 170.48 -120.81
Income/Loss From Continuing Operations Before Tax
-101.80
- 1.267 294.12 35.14
Income/Loss From Continuing Operations After Tax
14.79%
-101.80
-119.47 -99.35 183.38 -109.78
Net Income/Loss
14.79%
-101.80
-119.47 -99.35 183.38 -109.78
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
50,597%
149.40
0.2947 137.64 137.05 136.52
Diluted Average Shares
50,597%
149.40
0.2947 137.64 140.93 136.52
Basic Earnings Per Share
21.84%
-0.68
-0.87 -0.72 1.34 -0.80
Diluted Earnings Per Share
21.84%
-0.68
-0.87 -0.72 1.30 -0.80
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$60.58
price down icon 3.01%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
Capitalizzazione:     |  Volume (24 ore):